Browse News
Filter News
Found 9,368 articles
-
Ten pharmaceutical companies have joined forces again to launch Accumulus Synergy Inc., a non-profit effort to pool data in the cloud and interact with regulators, in the hopes of speeding the drug approval process.
-
Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19
1/22/2021
Initial agreement provides up to 40 million doses to COVAX in 2021 First deliveries are expected to take place in Q1 2021 subject to the execution of supply agreements under the COVAX Facility structure
-
Ten Leading BioPharma Companies Announce Formation of Accumulus Synergy to Develop Global Data Sharing Platform
1/22/2021
Ten of the world’s leading biopharmaceutical companies today announced the formation of a new non-profit corporation, Accumulus Synergy, Inc., which is intended to support interactions between industry and health authorities worldwide to enable real-time collaboration and data exchange, as well as data submission.
-
Hemophilia Treatment Market: Top 4 factors fueling the industry outlook through 2025
1/22/2021
The global hemophilia treatment market is expected to accumulate considerable returns in the coming years due to the growing cases of genetic abnormalities as well as the prevalence of hemophilia. Hemophilia is a rare bleeding condition, that leads to prolonged bleeding after an injury or a surgery owing to a delay in blood clotting.
-
The jury is still out on whether Roche’s arthritis drug, Actemra/RoActemra (tocilizumab), is helpful for the most severe cases of COVID-19.
-
China Jo-Jo Drugstores Hosts the First Suppliers Conference in China - Jan 21, 2021
1/21/2021
China Jo-Jo Drugstores, Inc., a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, announced that the Company hosted its first suppliers conference in Haiwaihai International Conference Center of Hangzhou, China at the end of December 2020, which was attended by approximately 200 representatives of its suppliers.
-
Dynacure Announces Appointment of Jean M. Franchi to its Board of Directors
1/21/2021
Dynacure, a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options, announced the appointment of Jean M. Franchi to its Board of Directors.
-
Biotechnology Market | Exclusive Research Report on the Market Trends and Revenues
1/21/2021
The global biotechnology market is mainly driven by the surge in the demand for food, depleting natural resources, government regulatory support, and technological advancements of various solutions to counter fatal diseases.
-
Glucocorticoid Drugs Market: Allergies & Asthma to Lead Global Market
1/21/2021
Glucocorticoid drugs are synthetic versions of glucocorticoids; steroids that are naturally occurring compounds in the body. These have several functions.
-
Atrial Fibrillation Drugs Market: 4 major trends fueling the industry share through 2025
1/21/2021
The atrial fibrillation drugs market is forecasted to record lucrative growth on account of large presence of geriatric population base that is susceptible to valvular diseases.
-
Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors
1/20/2021
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that Phillip Schneider and Paul Sekhri have been appointed to its board of directors. "As we continue to make significant progress at Longboard, one of our top priorities is to assemble an experienced team, beginning with our leadership team and board of directors. Leveraging t
-
Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
1/20/2021
Today, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced results from an in vitro study that provides additional data on the capability of sera from individuals immunized with the Pfizer-BioNTech COVID-19 vaccine BNT162b2 to neutralize the SARS-CoV-2 U.K. strain, also known as B.1.1.7 lineage or VOC 202012/01.
-
AVM Biotechnology's Executive Leadership Team Joined by Dr. Manon Cox, MBA, former Protein Sciences Corporation CEO and Dr. Gary Grohmann, former Australian Regulatory Official
1/20/2021
Dr. Manon Cox will assume the role of CEO and Dr. Gary Grohmann the role of Chief Regulatory Officer, while retaining their positions on the Board of Directors, along with existing member Michael Bernard , JD, Chief Tax Officer for Vertex, Inc.
-
Ligand’s Fourth Quarter Financial Results to be Reported February 3rd
1/20/2021
Ligand’s Fourth Quarter Financial Results to be Reported February 3 rd
-
CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021
1/20/2021
The recently hosted CPhI & P-MEC China 2020 – organized by Informa Markets and CCCMHPIE and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd. – attracted a remarkable 46,157 visits of professional pharma visitors, including 5,105 international attendees taking part online.
-
Asthma Treatment Drugs Receive Fillip during COVID-19, Future Expansion Banking on Rising Generic Drug Candidates Popularity: Fact.MR
1/20/2021
Fact.MR, Dublin: The global asthma treatment market is likely to embark on a positive growth trajectory, attributed to burgeoning investment volumes in developing long-term and quick-relief medications, according to award winning market research company Fact.MR.
-
Antihistamines Market: Tablets & capsules segment is projected to account for the dominant share of global market
1/20/2021
Antihistamines are a class of drugs that inhibit the action of histamine by attacking the specific cell receptors meant for histamines.
-
Pharmaceutical Intermediates Market: Rising Demand for Drugs for a Range of Lifestyle medications is Propelling the Market Demand
1/20/2021
Pharmaceutical intermediates are the key chemical ingredients in active pharmaceutical ingredients that are used in making medications for the treatment of diseases.
-
Alice Pomponio Named Managing Director of American Cancer Society's BrightEdge
1/19/2021
The American Cancer Society announced that life sciences industry leader Alice Pomponio has been named managing director of BrightEdge, the ACS philanthropic impact fund that invests in companies to accelerate the Society's mission to fight cancer.
-
SwanBio Therapeutics Appoints Alison Lawton to Board of Directors
1/19/2021
SwanBio Therapeutics (SwanBio), a gene therapy company advancing AAV-based therapies for the treatment of devastating, genetically defined neurological conditions, today announced the appointment of Alison Lawton to the company’s Board of Directors.